1. Home
  2. IRTC vs GKOS Comparison

IRTC vs GKOS Comparison

Compare IRTC & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRTC
  • GKOS
  • Stock Information
  • Founded
  • IRTC 2006
  • GKOS 1998
  • Country
  • IRTC United States
  • GKOS United States
  • Employees
  • IRTC N/A
  • GKOS N/A
  • Industry
  • IRTC Medical/Dental Instruments
  • GKOS Medical/Dental Instruments
  • Sector
  • IRTC Health Care
  • GKOS Health Care
  • Exchange
  • IRTC Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • IRTC 5.8B
  • GKOS 5.4B
  • IPO Year
  • IRTC 2016
  • GKOS 2015
  • Fundamental
  • Price
  • IRTC $172.20
  • GKOS $82.11
  • Analyst Decision
  • IRTC Strong Buy
  • GKOS Strong Buy
  • Analyst Count
  • IRTC 11
  • GKOS 12
  • Target Price
  • IRTC $163.82
  • GKOS $128.58
  • AVG Volume (30 Days)
  • IRTC 378.5K
  • GKOS 698.9K
  • Earning Date
  • IRTC 10-29-2025
  • GKOS 11-03-2025
  • Dividend Yield
  • IRTC N/A
  • GKOS N/A
  • EPS Growth
  • IRTC N/A
  • GKOS N/A
  • EPS
  • IRTC N/A
  • GKOS N/A
  • Revenue
  • IRTC $657,227,000.00
  • GKOS $432,953,000.00
  • Revenue This Year
  • IRTC $25.11
  • GKOS $28.79
  • Revenue Next Year
  • IRTC $16.65
  • GKOS $25.65
  • P/E Ratio
  • IRTC N/A
  • GKOS N/A
  • Revenue Growth
  • IRTC 22.37
  • GKOS 26.70
  • 52 Week Low
  • IRTC $55.92
  • GKOS $77.10
  • 52 Week High
  • IRTC $187.57
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • IRTC 51.86
  • GKOS 35.01
  • Support Level
  • IRTC $167.28
  • GKOS $80.52
  • Resistance Level
  • IRTC $187.57
  • GKOS $95.32
  • Average True Range (ATR)
  • IRTC 4.64
  • GKOS 2.86
  • MACD
  • IRTC -1.49
  • GKOS -1.19
  • Stochastic Oscillator
  • IRTC 24.25
  • GKOS 9.65

About IRTC iRhythm Technologies Inc.

iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: